[Studies of the effectivity of blood vessel-active drugs with 133Xe muscle clearance].
D000328:Adult; D001027:Aortography; D001158:Arteries; D002196:Capillaries / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007269:Injections, Intra-Arterial; D007273:Injections, Intramuscular; D007925:Leriche Syndrome / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D009132:Muscles / Q000098:blood supply*; D009539:Nicotinic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012039:Regional Blood Flow / Q000187:drug effects*; D013806:Theophylline / Q000494:pharmacology* / Q000627:therapeutic use; D014586:USSR / Q000188:drug therapy; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014978:Xenon
D009539:Nicotinic Acids; D011868:Radioisotopes; D014665:Vasodilator Agents; D014978:Xenon; D013806:Theophylline
Untersuchungen zur Wirksamkeit gefässaktiver Medikamente mit der 133Xe-Muskelclearance.